Performance of HemosIL ReadiPlasTin, a Liquid Reagent for Prothrombin Time Measurement
10.15263/jlmqa.2019.41.1.9
- Author:
Saeam SHIN
1
;
Yunjung JUNG
;
Wonkeun SONG
;
Min Jeong PARK
Author Information
1. Department of Laboratory Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. mjpark@hallym.or.kr
- Publication Type:Original Article
- Keywords:
Blood coagulation tests;
Prothrombin time;
Thromboplastin
- MeSH:
Blood Coagulation Disorders;
Blood Coagulation Tests;
Mass Screening;
Prothrombin Time;
Prothrombin;
Thromboplastin
- From:Journal of Laboratory Medicine and Quality Assurance
2019;41(1):9-12
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Prothrombin time (PT) measurement is an important test for screening blood coagulation disorders and monitoring anticoagulant therapy. In this study, we evaluated the analytical performance of HemosIL ReadiPlasTin (Instrumentation Laboratory, USA), a liquid reagent for PT measurement. METHODS: The precision of HemosIL ReadiPlasTin was evaluated according to the Clinical and Laboratory Standards Institute (CLSI) EP5-A3 guidelines. Further, comparison with HemosIL RecombiPlasTin 2G (Instrumentation Laboratory, USA) was made according to the CLSI EP9-A3 guidelines. The reference intervals were established according to the CLSI C28-A3 guidelines. RESULTS: The coefficient of variation values for repeatability and total imprecision at two levels of control materials were lower than 1.1% and 3.4%, respectively. The performance of HemosIL ReadiPlasTin was comparable to that of HemosIL RecombiPlasTin 2G, with a high correlation (r=0.996). The reference interval for normal subjects was 10.4–13.3 seconds. CONCLUSIONS: HemosIL ReadiPlasTin showed an acceptable degree of imprecision and its performance showed high correlation with that of a conventional reagent. Therefore, it is expected to be useful for PT measurement in clinical laboratories.
